Patents by Inventor Da Gong Wang

Da Gong Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7592145
    Abstract: This invention provides methods for diagnosing prostate cancer, methods for measuring the aggressiveness of prostate cancer, and methods for identifying prostate cancer likely to metastasize. The diagnostic and prognostic assays of this invention include methods involving the antibody-based detection of Pin1 and the amplification of Pin1 RNA. The diagnostic and prognostic assays of this invention may be used in combination with other methods of prostate cancer diagnosis including the PSA test, digital rectal exam, and Gleason prostate tumor grading system.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: September 22, 2009
    Assignee: Pintex Pharmaceuticals, Inc.
    Inventors: Lere Bao, Da Gong Wang
  • Patent number: 7501255
    Abstract: Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. The levels of Pin1 can be protein levels or nucleic acid levels.
    Type: Grant
    Filed: November 14, 2003
    Date of Patent: March 10, 2009
    Assignee: Pintex Pharmaceuticals, Inc.
    Inventor: Da Gong Wang
  • Publication number: 20040171036
    Abstract: Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1 . The levels of Pin1 can be protein levels or nucleic acid levels.
    Type: Application
    Filed: November 14, 2003
    Publication date: September 2, 2004
    Inventor: Da Gong Wang
  • Publication number: 20030073096
    Abstract: This invention provides methods for diagnosing prostate cancer, methods for measuring the aggressiveness of prostate cancer, and methods for identifying prostate cancer likely to metastasize. The diagnostic and prognostic assays of this invention include methods involving the antibody-based detection of Pin 1 and the amplification of Pin 1 RNA. The diagnostic and prognostic assays of this invention may be used in combination with other methods of prostate cancer diagnosis including the PSA test, digital rectal exam, and Gleason prostate tumor grading system.
    Type: Application
    Filed: February 8, 2002
    Publication date: April 17, 2003
    Applicant: Pintex Pharmaceuticals, Inc.
    Inventors: Lere Bao, Da Gong Wang
  • Publication number: 20030068626
    Abstract: Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In one embodiment, the method includes detecting a level of Pin1 to stage an abnormal cell growth, such as breast or prostate cancer. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the method includes evaluating the extent of metastasis of abnormal cell growth, such as cancer. The levels of Pin1 can be protein levels or nucleic acid levels.
    Type: Application
    Filed: February 8, 2002
    Publication date: April 10, 2003
    Applicant: Pintex Pharmaceuticals, Inc.
    Inventors: Da Gong Wang, Lere Bao